Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Thor Medical ASA Proxy Solicitation & Information Statement 2026

Apr 10, 2026

3679_rns_2026-04-10_42e1c8b0-41b0-4e5c-8b83-c4894d3b4a37.html

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

Thor Medical ASA - Nomination committee recommendation to the Annual General Meeting

Thor Medical ASA - Nomination committee recommendation to the Annual General Meeting

10.4.2026 09:51:08 CEST | Thor Medical ASA | Additional regulated information

required to be disclosed under the laws of a member state

9 April 2026 | Thor Medical ASA | Additional regulated information required to

be disclosed under the laws of a member state

The nomination committee has made its recommendation to the Annual General

Meeting of Thor Medical ASA that will be held on 23 April 2026, at 14:00 hours

CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The recommendation

and the previously distributed notice are not fully aligned, and the company

wishes to clarify that the proposed resolutions for the general meeting are as

set out in the nomination committee's recommendation with respect to the matters

it concerns.

The recommendation of the nomination committee is attached and is also available

on www.thormedical.com - https://www.thormedical.com.

For further information please contact:

Mathias Nilsen Reierth

Head of Communications and Corporate Affairs

Tel: +47 988 05 724

[email protected]

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle

emitters, from naturally occurring thorium. Its proprietary production process

requires no irradiation or use of nuclear reactors, and provides reliable,

environmentally friendly, cost-efficient supply of alpha-emitters for the

radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and

listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visit www.thormedical.com - http://www.thormedical.com

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the

Securities Trading Act.

ATTACHMENTS

a4feec3c-84ad-4bec-b2e1-e467204eb501.pdf -

https://kommunikasjon.ntb.no/ir-files/17848634/18858270/7031/a4feec3c-84ad-4bec-

b2e1-e467204eb501.pdf

Thor Medical - Nomination Committee proposal 2026.pdf -

https://kommunikasjon.ntb.no/ir-files/17848634/18858270/7030/Thor%20Medical%20-%

20Nomination%20Committee%20proposal%202026.pdf